Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
Atossa to Participate in Fireside Chat at Healthcare Virtual Conference Presented by Maxim Group LLC
-
Atossa Therapeutics Announces Pricing of $25.2 Million Registered Direct Offering Priced At-The-Market
-
Atossa Therapeutics (ATOS) Announces Pricing of $14 Million Registered Direct Offering of Common Stock, Warrants
-
Atossa Therapeutics Announces Pricing of $14.0 Million Registered Direct Offering Priced At-The-Market
-
Atossa Therapeutics (ATOS) Prices Offering for Gross Proceeds of $20M
-
Atossa Therapeutics Announces Pricing of $20.0 Million Underwritten Public Offering
-
Atossa Genetics (ATOS) PT Raised Doubled to $8 at Maxim Group
-
Maxim Group Upgrades Atossa Genetics (ATOS) to Buy
-
Maxim Group Downgrades Atossa Genetics (ATOS) to Hold
-
Atossa Genetics (ATOS) PT Raised to $9 at Maxim Group
-
Atossa Genetics (ATOS) PT Lowered to $7 at Maxim Group, Reit. 'Buy'
-
Atossa Announces $13.4 Million in Expected Gross Proceeds from Recently Expired Rights Offering
-
Atossa Genetics Reminds Investors of Today’s Deadline to be a Shareholder of Record
-
Atossa Genetics Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
-
Pre-Open Stock Movers 01/26: (EGHT) (ABBV) (INTC) Higher; (SBUX) (BBBY) (ETFC) Lower (more...)
-
Maxim Group Starts Atossa Genetics (ATOS) at Buy
-
Atossa Genetics (ATOS) Prices 5.3M Share Registered Direct Offering at $0.315/Sh
-
Atossa Genetics Announces Pricing of $1.4 Million Registered Direct Offering
-
Atossa Genetics Announces Closing of $5.5 Million Common Stock Public Offering and Over-allotment Option
-
Atossa Genetics (ATOS) Pricing of 11.5M Public Offering of Common Stock at $0.44/Share
-
Atossa Genetics Announces Pricing of $5.1 Million Public Offering of Common Stock
-
Atossa Genetics (ATOS) Announces Common Share Offering
-
Atossa Genetics Announces Proposed Public Offering of Common Stock
-
Pre-Open Stock Movers 9/24: (LPCN) (MACK) (ACOR) Higher; (ECTE) (ATOS) (GTI) Lower (more...)
-
After-Hours Stock Movers 9/23: (LPCN) (BBBY) (ZSPH) Higher; (ATOS) (GTI) (AIR) Lower (more...)
-
Pre-Open Stock Movers 9/18: (ATOS) (AFOP) (ADBE) Higher; (SGMO) (FIVE) (FLTX) Lower (more...)